How much is the gamma knife market worth?

The market size of gamma knife in 2027 is calculated to be USD 524.99 million.

How is the gamma knife industry expected to grow over the next 10 years?

Gamma Knife Market size was around USD 504.8 million in 2026 and is slated to grow at a 4.75% CAGR from 2027 to 2036, exceeding USD 802.9 million by 2036.

How are frameless gamma knife innovations influencing hospital investment decisions?

Frameless systems improve treatment precision, simplify workflows, and enhance patient experience, making hospitals and specialty centers more willing to invest in platforms that support higher throughput and modern image-guided radiosurgery practices.

Why is the shift toward minimally invasive neurosurgery supporting growth in the gamma knife market?

Hospitals are investing in gamma knife systems to expand non-incisional treatment options, strengthen comprehensive brain care services, improve referral retention, and reduce reliance on resource-intensive surgical procedures.

What makes malignant tumors the largest indication segment in the gamma knife market?

Malignant tumors held a 48.44% market share in 2026, supported by sustained demand for precise intracranial treatment approaches that help control lesions while minimizing damage to surrounding brain tissue.

Why are benign tumors the fastest-growing indication for gamma knife treatment?

Benign tumors are growing fastest because clinicians increasingly favor highly targeted radiosurgery that preserves neurological function and reduces the procedural burden associated with open surgical interventions.

Why does North America lead the gamma knife market?

North America leads due to advanced neurosurgical centers, strong imaging infrastructure, established radiosurgery workflows, and consistent procedural adoption for complex neurological and tumor cases.

What is driving Asia Pacific’s growth in the gamma knife market?

Asia Pacific grows at 5.88% CAGR due to rising investment in specialized cancer and neurological care, expanding radiosurgery capacity, and growing adoption of non-invasive precision treatment systems.

What are the key competitors in the gamma knife landscape?

Leading players in the gamma knife market include Elekta AB (Sweden), Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (United States), Varian Medical Systems, Inc. (United States), Huiheng Medical, Inc. (China), Masep Medical Science & Technology Development Co., Ltd. (China), Accuray Incorporated (United States), Brainlab AG (Germany).